Callitrichid hepatitis is an acute, often fatal viral infection of New World primates which occurs in zoo collections of these animals (10, 12) . The etiologic agent, callitrichid hepatitis virus (CHV), is an ultrastructurally typical arenavirus that is recognized by antibodies specific for Old World arenaviruses (16, 17) . Although these immunologic studies (16, 17) strongly suggest that callitrichid hepatitis is caused by lymphocytic choriomeningitis virus (LCMV), cross-hybridization studies with probes from the 5Ј end of the S RNA of LCMV and a CHV isolate suggest that significant sequence differences between these two viruses may exist (11) . In view of this possibility, we have cloned and sequenced the GP-C gene of CHV to determine its exact relationship to LCMV.
The GP-C gene of CHV was amplified by reverse transcription-PCR. Viral RNA for cDNA synthesis was prepared (5) from two sources: (i) directly from the liver of an experimentally inoculated marmoset (EXP3 [17] ) and (ii) from a thricepassaged Vero cell isolate derived from a second marmoset (EXP2) infected with the same inoculum. First-strand cDNA synthesis was performed with Moloney murine leukemia virus reverse transcriptase (Bethesda Research Laboratories, Bethesda, Md.) and the antigenome-sense primers LCMV2 and LCMV5 (see Fig. 1 ). PCR amplification was performed with one of these primers plus one of three genome-sense primers (see Fig. 1 ) (0.25 M) by using Taq polymerase (0.04 U/l; Promega, Madison, Wis.), the manufacturer's buffer (containing 1.5 mM Mg), and deoxynucleoside triphosphates (0.1 mM each). Although reaction conditions varied in minor ways, a typical PCR profile involved a hot start (95 to 98ЊC for 1 min) followed by annealing, extension, and melting for 40 or 41 cycles. The profiles used for each clone were as follows: CHV-1, annealing at 37ЊC for 2 min, extension at 72ЊC for 3 min, and melting at 94ЊC for 1 min; CHV-2, annealing at 45ЊC for 2 min, extension at 72ЊC for 3 min, and melting at 94ЊC for 1 min; CHV-3, annealing at 45ЊC for 1 min, extension at 72ЊC for 2 min, and melting at 94ЊC for 1 min; and CHV-4, annealing at 50ЊC for 1 min, extension at 72ЊC for 1.5 min, and melting at 94ЊC for 1 min. Amplification products of the appropriate size were subcloned into the pCR1000 vector with the TA cloning system (Invitrogen, San Diego, Calif.). Inserts were sequenced completely in both directions with Sequenase 2.0 (U.S. Biochemical, Cleveland, Ohio), plasmid region primers, the PCR primers, and additional sequencing primers (not shown). Sequence analysis was performed with the Genetics Computer Group software package (7) .
Four clones were sequenced (Fig. 1 ). CHV-1 was amplified from liver-derived RNA with primers LCMV1 and LCMV2 (derived from LCMV-WE and LCMV-Armstrong sequences), which are located just inside each end of the GP-C open reading frame (ORF). To confirm that the GP-C gene of CHV has the same initiation and stop codons as the GP-C genes of LCMV-Armstrong and -WE, we tried to amplify the intact ORF plus upstream and downstream regions by using primers from the highly conserved 5Ј end of the S RNA (LCMV4) and from the 3Ј end of the nucleocapsid protein gene (which is translated from antigenome-sense RNA) near the 3Ј end of the GP-C ORF (LCMV5). The resulting clone (CHV-2) appeared to have a 51-nucleotide deletion (on the basis of a comparison with LCMV-Armstrong and -WE) spanning bases 1562 to 1612 (base 1 being the 5Ј terminus of the S RNA) and covering the extreme 3Ј end of the GP-C ORF plus most of the intergenic region. After further attempts to clone the intact ORF with these primers failed (we used higher annealing temperatures to melt a possible secondary structure in the intergenic region which may have caused the deletion), we amplified each end of the GP-C gene independently. First, we amplified all but the 3Ј end of the GP-C ORF from liver-derived RNA, using primers LCMV4 and LCMV2 (clone CHV-3). We then used a primer near the 3Ј end of the GP-C gene (primer CHV4, based on the CHV sequence) and successfully amplified the 3Ј end of that gene plus the (apparently) complete intergenic region (clone CHV-4). The overlapping nucleotide sequences of CHV-2 and CHV-4 were identical (see legend to Fig. 2 ), and these sequences are hereafter referred to jointly as CHV-2/4.
Analysis of the cDNA and deduced amino acid sequences of CHV revealed that this virus is as closely related to LCMV strains Armstrong and WE as these two strains are to one another. The CHV cDNA sequences are 84 to 86% identical to the LCMV cDNA sequences, while the deduced amino acid sequences are 95 to 96% identical ( Table 1) . As expected from this high degree of similarity, many functionally important domains are conserved in these GP-C sequences (Fig. 2) . For example, GP-C is cleaved between amino acids 265 and 266 to yield the virion surface glycoproteins GP-1 and GP-2, and GP-1 is further cleaved between amino acids 58 and 59 to release the amino-terminal signal sequence (2) . The location and sequence of these cleavage sites in the CHV clones are identical to those of the LCMV sites. In addition, all of the nine potential N-linked glycosylation sites in GP-C are conserved (6). Overlapping epitopes defined by two monoclonal antibodies have been mapped to a region consisting of amino acids 370 through 382 of LCMV (18) . These antibodies were previously shown to react with CHV (16), and, as expected, the deduced amino acid sequence of this region of the CHV clones is identical to that of LCMV strains WE and Armstrong. In view of the high degree of similarity between the GP-C genes of CHV and LCMV, CHV should be considered a strain of LCMV.
Interesting differences in the three deduced amino acid sequences from the CHV clones were seen. Sequences from the two clones derived directly from the same infected liver (CHV-1 and CHV-3) are almost identical, with 3 nucleotide differences seen in a total overlap region of 1,461 nucleotides. Two of these changes resulted in amino acid differences. The H-to-L change at amino acid 260 in GP-1 is interesting because an F-to-L mutation at this site has been previously associated with changes in the ability of LCMV clone 13 to infect macrophages and was also associated (along with a mutation in the polymerase gene) with the development of persistent rather than acute infections in mice (9) . Four additional amino acid differences were found when the cell-culture-derived sequences (CHV-2/4) were compared with the liver-derived sequences. Two basic residues (K) and one neutral residue (N) in the liver sequences were all changed to glutamate (E), an acidic residue, in the cell culture sequences. (One K-to-E change occurred in the signal sequence.) The fourth change (N to S) was more conservative. All of these changes occurred in GP-1, the viral protein which appears to be responsible for interaction with the cellular receptor (1), raising the possibility that these changes reflect differences between virus-cell interactions in cell culture and those in primate hosts.
The level of sequence variation seen among these strains of LCMV (including CHV) would be considered unusually high for independent isolates of many human RNA viruses but is not unexpected for RNA viruses which persist in animal reservoirs having limited geographic mobility (such as the reservoir of LCMV, Mus musculus). The restricted geographic range of such animal reservoirs permits the development of distinct viral lineages which diverge from one another over time. The morbilliviruses provide an example of this phenomenon. Geographically isolated strains of rinderpest virus (which infects cattle and buffalo) show 6% divergence in the amino acid sequence of the fusion (F) protein (3) within a 10-year period, while the variation seen in the F protein of measles virus over a longer time span is Յ1% (13, 14) . The greater genetic variation of such zoonotic viruses could result in significant phenotypic differences among isolates from different geographic regions. Such phenotypic differences might affect the pathogenic potential of viruses which infect humans.
The frequent occurrence of callitrichid hepatitis outbreaks (11, 12) , together with recent serologic studies showing a 5% prevalence of serum antibody against LCMV in urban U.S. populations (4, 15) and the continued identification of sporadic a Amino acid sequence identities are given in the lower left part of the table, and nucleotide sequence identities are given in the upper right part. The CHV-2/4, Armstrong, and WE sequences analyzed here cover all 499 codons (including the stop codon), CHV-1 lacks the first 7 and final 5 codons, and CHV-3 lacks the final 5 codons. The comparison was made with the Genetics Computer Group program Distances by using a threshold of comparison of 1.00 and a denominator equal to the length of the shorter sequence (the sequences contained no gaps).
cases of symptomatic human infections (8) , suggests that LCMV may be more widely distributed in the United States than has been thought. Since LCMV can cause significant human disease, a wider application of diagnostic assays to determine the actual incidence of LCMV-associated disease in appropriate clinical populations would be prudent.
Nucleotide sequence accession numbers. The CHV sequences determined in this study have been submitted to GenBank under accession numbers U10157 (CHV-1), U10158 (CHV-2/4), and U10159 (CHV-3).
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